The abstract is read at the publisher; the summary is JClub's.
Loss of chromosome 6q in ultra-high-risk posterior fossa A ependymoma is linked to deletion of LATS1, dysregulating Hippo signaling and elevating YAP/TEAD activity.
- Why it matters: Ultra-high-risk PFA ependymoma relapse is typically terminal, and while 1q+ biology is known, the mechanisms and vulnerabilities of 6q- disease remain unclear.
- What they did: Integrated clinical, multiomic, and functional analyses of primary and recurrent PFA ependymomas identified recurrent LATS1 deletion across 6q- cases, including 10/60 with partial 6q deletions, and tested LATS1 restoration and Hippo-targeting drugs.
- The result: Restoring LATS1 in 6q- cell lines suppressed proliferation, and TEAD2 palmitoylation inhibitor VT107 and PROTAC degrader H122 showed PFA 6q- selective activity in vitro, with cumulative 6q loss linked to nearly half of PFA ependymoma-related deaths.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.